The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Myasthenia gravis and myasthenic syndromes
Abstract
More than a decade ago myasthenic symptoms were observed in rabbits immunized with acetylcholine receptor (AChR) {119} and AChR deficiency was found at the neuromuscular junction in human myasthenia gravis (MG) {36}. By 1977 the autoimmune character of MG and the pathogenic role of AChR antibodies had been established by several measures. These included the demonstration of circulating AChR antibodies in nearly 90% of patients with MG {87}, passive transfer with IgG of several features of the disease from human to mouse {149}, localization of immune complexes (IgG and complement) on the postsynaptic membrane {30}, and the beneficial effects of plasmapheresis {20, 123}. Substantial subsequent progress has occurred in understanding the structure and function of AChR and its interaction with AChR antibodies. The relationships of the concentration, specificities, and functional properties of the antibodies to the clinical state in MG have been carefully analyzed, and the mechanisms by which AChR antibodies impair neuromuscular transmission have been further investigated. The clinical classification of MG has been refined, the role of the thymus gland in the disease has been further clarified, and new information has become available on transient neonatal MG. The prognosis for generalized MG is improving, but there is still no consensus on its optimal management. Novel therapeutic approaches to MG are now being explored in animal models. Recognition of the autoimmune origin of acquired MG also implied that myasthenic disorders occurring in a genetic or congenital setting had a different cause. As a result, a number of congenital myasthenic syndromes have come to be recognized and investigated. Finally, an acquired disorder of neuromuscular transmission different from MG, the Lambert‐Eaton myasthenic syndrome, has also been shown to have an autoimmune basis. In this syndrome, active zone particles of the presynaptic membrane are direct or indirect targets of the pathogenic autoantibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eaton‐Lambert syndrome: Acetylcholine and choline acetyltransferase in skeletal muscle
Molenaar, P. C., Newsom-Davis, J., Polak, R. L., & Vincent, A. (1982) · Neurology · doi:10.1212/wnl.32.9.1061 · Cited by 47
Cited by
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Vincent, A., Palace, J., & Hilton-Jones, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05186-2 · Cited by 452
Tindall, R. S. A., Rollins, J. A., Phillips, J. T., Greenlee, R. G., Wells, L., & Belendiuk, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161205 · Cited by 394
Dalmau, J., Furneaux, H. M., Gralla, R. J., Kris, M. G., & Posner, J. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270515 · Cited by 393
Metadata
- Authors
- Engel, A. G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1984-11
- Volume
- 16
- Issue
- 5
- Pages
- 519-534
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2169423335
- Cited by
- 240
- References
- 1
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myasthenia gravis and myasthenic syndromes. https://app.cochat.ai/papers/10.1002/ana.410160502
- The paper
- Engel, A. G. (1984). Myasthenia gravis and myasthenic syndromes. Annals of Neurology. https://doi.org/10.1002/ana.410160502
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.